Manulife (Manufacturers Life Insurance)
KRON

Manulife (Manufacturers Life Insurance)’s Kronos Bio KRON Stock Holding History

Manulife (Manufacturers Life Insurance)’s Portfolio KRON Stock Details KRON Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q4 		– Sell
-14,467
Closed -$48.5K – 2985
2022
Q3 		$48.5K Buy
+14,467
New +$65.3K ﹤0.01% 2915
2022
Q2 		– Sell
-22,829
Closed -$166K – 3075
2022
Q1 		$166K Buy
22,829
+1,590
+7% +$13.6K ﹤0.01% 2837
2021
Q4 		$298 Buy
21,239
+1,167
+6% +$18.3K ﹤0.01% 2607
2021
Q3 		$421K Sell
20,072
-1,610
-7% -$34.6K ﹤0.01% 2420
2021
Q2 		$519K Buy
21,682
+13,047
+151% +$330K ﹤0.01% 2402
2021
Q1 		$253K Buy
8,635
+219
+3% +$6.42K ﹤0.01% 2732
2020
Q4 		$251K Buy
+8,416
New +$264K ﹤0.01% 2625

Other funds holding KRON

OFM
Omega Fund Management Boston, Massachusetts $163M AUM 107.06% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
VVA
Vida Ventures Advisors Boston, Massachusetts $29.4M AUM 93.58% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return
AG
Artal Group Luxembourg $1.01B AUM 29.84% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
NI
Nextech Invest Zurich, Switzerland $1.42B AUM 304.47% 1-Year Est. Return
AI
Alphabet Inc Mountain View, California $99.1B AUM 124.46% 1-Year Est. Return
WCM
Wildcat Capital Management New York $229M AUM 132.65% 1-Year Est. Return

Manulife (Manufacturers Life Insurance)'s KRON Position: Q4 2022 in Review

Manulife (Manufacturers Life Insurance) sold out of Kronos Bio (KRON) in Q4 2022, closing a stake of 14,467 shares — an estimated $48.5K sold.

Manulife (Manufacturers Life Insurance) first reported a position in KRON in Q4 2020 and held it in 7 quarters. The position peaked at $519K in Q2 2021. 97 funds tracked by Wall St. Rank hold KRON as of Q4 2022.

  • Manulife (Manufacturers Life Insurance) reported no remaining Kronos Bio position as of Q4 2022 after selling out during the quarter.
  • Manulife (Manufacturers Life Insurance) sold 14,467 Kronos Bio shares in Q4 2022, an estimated $48.5K.
  • Manulife (Manufacturers Life Insurance) first reported a position in Kronos Bio in Q4 2020 and held it in 7 quarters.
  • Manulife (Manufacturers Life Insurance)'s Kronos Bio position peaked at $519K in Q2 2021.
  • 97 funds tracked by Wall St. Rank held Kronos Bio as of Q4 2022.

Based on Manulife (Manufacturers Life Insurance)'s 13F filing for Q4 2022, filed 13 Feb 2023.